April 22, 2024

bioRN M2M with Cytion | Your Cell Culture Questions Answered

bioRN M2M with Cytion | Your Cell Culture Questions Answered

Join Cytion and bioRN for expert insights at the upcoming bioRN Member to Member session: Your Questions on Cell Lines, Cell Culture and Cell Banking answered. Get practical answers to real-world challenges.

On 15 July, we are visiting Cytion:  for a practical discussion on the challenges researchers encounter every day when working with cell cultures. Rather than a traditional company presentation, this session focuses on practical experience, troubleshooting and lessons learned from everyday laboratory work.

Submit your question during registration and selected questions will be discussed live during the event. Plus: Get an exclusive behind-the-scenes look at Cytion’s facilities and learn what happens before a cell line ever reaches your lab.

Cytion is a global leader in authenticated cell lines, serving as a trusted repository of high-quality, contamination-free biological resources. Founded in 2004 as Cell Lines Service, the company has curated over 1,000 cell lines from diverse tumors, tissues, and species. Its mission is to safeguard scientific assets and provide researchers with reliable research reagents. With services including Cell Banking, Cell Culture Scale-Up, Assay-Ready Cell Manufacture, STR analysis, and mycoplasma testing, Cytion ensures authenticity and reproducibility – empowering innovation and advancing research, cell by cell.

Grab your coffee or lunch and dial in: 

When: July 15 at 12pm, digital (Zoom) – Register via the Link and submit your questions in advance. You will receive the Zoom link after your registration.

Looking forward to seeing you there!

 

 

register now

Our latest News

discover more
Cardiac Arrhythmias: New Defibrillator System Expands Treatment Options at UKHD

Cardiac Arrhythmias: New Defibrillator System Expands Treatment Options at UKHD

At Heidelberg University Hospital (UKHD), there is a new treatment option for certain patients with severe cardiac arrhythmias: an implantable defibrillator in which the electrode—unlike in conventional defibrillators—is placed outside the heart and blood vessels. This protects the blood vessels. In addition, the system can correct some arrhythmias using mild electrical impulses before an electric […]

The Individual Genetic Background Shapes the Evolution of Cancer

The Individual Genetic Background Shapes the Evolution of Cancer

Why do cancers develop differently in different people—even when they are exposed to the same risk factors? An international research group, including the German Cancer Research Center (DKFZ), has now demonstrated in mice that an organism’s genetic makeup significantly influences the course of cancer development. The findings, now published in Nature, provide new insights into […]

Cell Signaling Technology Announces ISO 13485 Certification

Cell Signaling Technology Announces ISO 13485 Certification

Certification enables increased support for partners and customers with industry-leading antibody reagents for commercial applications. Danvers, MA, USA, July 16, 2026–Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced that its Beverly, MA, US and Leiden, NL facilities have achieved ISO 13485:2016 certification for […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp